HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Li, Z. Articles by Li, G. Y. Search for Related Content PubMed Articles by Li, Z. Articles by Li, G. Y.

Transmyocardial Laser Revascularization as Sole Therapy in Coronary Disease

Department of Cardiovascular Surgery Wanjie Hospital Zibo, Shandong People's Republic of China China

For reprint information contact: Li Guang Ying, MD Tel: 86 533 465 0000 Ext. 8211 Fax: 86 533 465 0830 Department of Cardiovascular Surgery, Wanjie Hospital, Zibo, Shandong Province 255213, People's Republic of China.

This prospective study evaluated the medium-term efficacy of transmyocardial laser revascularization as the sole therapy in patients with ischemic heart disease. A carbon dioxide laser was used to create channels through ischemic areas of the myocardium in 33 patients with a mean age of 58.8 ± 10.4 years. The mean left ventricular ejection fraction determined by echocardiography was 44.8% ± 14%. Preoperatively, the patients underwent coronary artery angiography, single photon emission computed tomography perfusion scans, and positron emission tomography metabolism scans to determine the extent and severity of ischemia and myocardial viability. Total follow-up of 327 patient-months was obtained for 26 patients with a mean follow-up of 12.6 ± 9 months. The scans were repeated at 3, 6, 12, and 24 months postoperatively. The perioperative mortality was 9% due to ventricular fibrillation. Morbidity was minimal. The number of perfusion defects decreased significantly after treatment and there was a significant increase in myocardial viability in the treated left ventricular free wall. The success rate, defined as a decrease of 2 angina classes, was approximately 80% during the follow-up, reflected in a significant decrease in the number of admissions for angina in the year after the procedure (mean, 0.5 ± 0.4) compared with the previous year (mean, 2 ± 1.1) and in decreased use of antianginal medications.